APP and Alzheimer disease: Growing evidence of gut dysbiosis in AD patients [6, 7] and animal models, including the 5xFAD, APP/PS1, and Tg2576 mouse models [8–11], demonstrates the importance of, and need for, further investigations into the role of the microbiome in AD.